Noticias de TEM_US
Noticias del mercado
Últimas noticias sobre TEM_US — 640 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Tempus AI to buy Personalis to strengthen its position in cancer screening
Tempus AI (NASDAQ:TEM) La brecha de acciones disminuye: ¿es hora de vender?
Hut 8, Tempus AI, SoundHound AI, Ambarella y Upstart son las cinco acciones de Inteligencia Artificial a tener en cuenta hoy, según MarketBeat
Tempus AI to buy Personalis to strengthen its position in cancer screening
Tempus to acquire Personalis for $1.5 billion By Investing.com
Tempus AI to acquire cancer-monitoring firm Personalis for $1.5B
Tempus AI (TEM) M&A announcement Summary
TEM’s Deal To Acquire PSNL Opens Door For $20B Cancer Market Opportunity – Retail Awaits To See Execution
Tempus AI (TEM) to Acquire Personalis (PSNL) for $1.5B in Strate
Tempus AI (TEM) to Acquire Personalis (PSNL) for $1.5B in Strate
Tempus AI (TEM) to Acquire Personalis (PSNL) for $1.5B in Strate
Tempus AI Announces Definitive Agreement to Acquire Personalis in Strategic All-Stock Merger Enhancing AI-Driven Oncology and Genomic Testing Capabilities
Tempus to buy Personalis (NASDAQ: PSNL) in $1.5B stock transaction
Tempus AI : Acquisition of PSNL Investor Deck
Personalis (NASDAQ: PSNL) agrees to $1.5B Tempus AI stock-and-cash deal
Tempus AI to Acquire Personalis in $1.5 Billion Deal
Tempus AI to Acquire Personalis in $1.5 Billion Enterprise Value Deal
Página 15 de 32